Shubo Du

机构：Nanjing Tech University, National University of Singapore, Anhui Medical University, Dalian University of Technology, Dalian University · ORCID：0000-0002-7913-986X

发表论文 43 篇 · 总被引 1582 次 · h-index 21

代表论文

• The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics (2023 · Chemical Reviews · 被引 152)
• Competition-Based Universal Photonic Crystal Biosensors by Using Antibody–Antigen Interaction (2019 · Journal of the American Chemical Society · 被引 112)
• Insulin-like Growth Factor 2 (IGF2)-Fused Lysosomal Targeting Chimeras for Degradation of Extracellular and Membrane Proteins (2023 · Journal of the American Chemical Society · 被引 74)
• Catalysis-based specific detection and inhibition of tyrosinase and their application (2020 · Journal of Pharmaceutical Analysis · 被引 68)
• Cell-Permeant Bioadaptors for Cytosolic Delivery of Native Antibodies: A “Mix-and-Go” Approach (2020 · ACS Central Science · 被引 55)
• Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy (2023 · Biomaterials · 被引 49)